Venetoclax in Combination With Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia: Clinical Experience From a Real-Life Setting

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览6
暂无评分
关键词
venetoclax,hypomethylating agents,low-dose,real-life
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要